Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.52 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ME2 | P23368 | 2/20 | 0.43 |
| ▸ | ME1 | P48163 | 2/20 | 0.43 |
| ▸ | ME3 | Q16798 | 2/20 | 0.43 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.42 |
| ▸ | DRD3 | P35462 | 2/20 | 0.42 |
| ▸ | DRD2 | P14416 | 1/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.41 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.41 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL462801 | 0.82 | CYP2C19 (0.48) | CYP2C19HIF1AMAPTKMT2AHSD11B1 | |
| SCHEMBL3703335 | 0.82 | CYP2C19 (0.53) | CYP2C19HIF1ATAAR1MAPTKMT2A | |
| SCHEMBL57411 | 0.81 | CYP2C19 (0.69) | CYP2C19HIF1ATAAR1MAPTKMT2A | |
| SCHEMBL10365625 | 0.81 | GRIN2D (0.47) | CYP2C19MAPTKMT2AME2ME1 | |
| Tert-Butylbenzene SCHEMBL27405309 | 0.79 | CYP2C19 (0.50) | CYP2C19HIF1AMAPTKMT2AHSD11B1 | |
| SCHEMBL1850 | 0.79 | CYP2C19 (0.55) | CYP2C19HIF1ATAAR1MAPTKMT2A | |
| SCHEMBL7739108 | 0.79 | CYP2C19 (0.61) | CYP2C19HIF1ATAAR1MAPTKMT2A | |
| Hydrochloric Acid SCHEMBL29090142 | 0.79 | CYP2C19 (0.67) | CYP2C19HIF1ATAAR1MAPTKMT2A | |
| SCHEMBL187685 | 0.78 | CYP2C19 (0.46) | CYP2C19HIF1ATAAR1MAPTKMT2A | |
| SCHEMBL2813766 | 0.78 | MAPT (0.55) | CYP2C19HIF1ATAAR1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 390 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4655373-A1 | BIODEGRADABLE PERFUME COMPOSITION | Givaudan SA (CH) | 2025-12-03 | — | — | EP | claimed |
| US-20250325463-A1 | COMPOSITIONS (III) | SYMRISE AG (DE) | 2025-10-23 | — | — | US | claimed |
| US-12398341-B2 | Apparatus and compositions for improving scent delivery | THE PROCTER & GAMBLE COMPANY (US) | 2025-08-26 | — | — | US | claimed |
| EP-4602141-A1 | A FRAGRANCE MIXTURE (VI) | Symrise AG (DE) | 2025-08-20 | — | — | EP | claimed |
| EP-4532646-A1 | A FRAGRANCE MIXTURE (V) | Symrise AG (DE) | 2025-04-09 | — | — | EP | claimed |
| US-20250099349-A1 | A FRAGRANCE MIXTURE | SYMRISE AG (DE) | 2025-03-27 | — | — | US | claimed |
| EP-4519403-A1 | A FRAGRANCE MIXTURE (V) | Symrise AG (DE) | 2025-03-12 | — | — | EP | claimed |
| EP-4472606-A1 | COMPOSITIONS (III) | Symrise AG (DE) | 2024-12-11 | — | — | EP | claimed |
| EP-4473079-A1 | A FRAGRANCE MIXTURE | Symrise AG (DE) | 2024-12-11 | — | — | EP | claimed |
| US-20240358611-A1 | COMPOSITIONS | SYMRISE AG (DE) | 2024-10-31 | — | — | US | claimed |
| WO-2016049404-A1 | SUBSTRATES COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049398-A1 | FRESHENING COMPOSITIONS AND DEVICES COMPRISING SAME | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| US-20160090555-A1 | CLEANING AND/OR TREATMENT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| WO-2016049455-A1 | PERSONAL CARE COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049407-A1 | ABSORBENT ARTICLE COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049395-A1 | PRODUCTS COMPRISING MALODOR REDUCTION MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| US-8609600-B2 | Encapsulation of bulky fragrance molecules | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-12-17 | — | — | US | claimed |
| CN-1520846-A | Quick-effective aerosol with plant aroma and its preparation | 丛繁滋 | 2004-08-18 | — | — | CN | claimed |
| CN-1475204-A | Medicinal Composition, dry powder vapor, nebula, nebula auxiliary preparation for use through mouth and nose and its preparation method | 丛繁滋 | 2004-02-18 | — | — | CN | claimed |
| US-4450296-A | 2-METHYL-2-PHENYL-HEXAN-4-ONE FROM A GRIGNARD REAGENT AND PROPIONIC ANHYDRIDE | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1984-05-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240358611-A1 | COMPOSITIONS | AZI2, NISCH, CIP2A | CYP2C19 1367/4885HIF1A 2543/4885TAAR1 1385/4885 |
| US-20250099349-A1 | A FRAGRANCE MIXTURE | PTMS, EP300, TRPA1 | CYP2C19 2956/4885HIF1A 1991/4885TAAR1 727/4885 |
| US-20250325463-A1 | COMPOSITIONS (III) | NISCH, TAS1R3, TAS2R3 | CYP2C19 591/4885HIF1A 901/4885TAAR1 2249/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.